Early Mobilisation in Intensive Care Unit : Interest of Cyclo-ergometry in Patients With Septic Chock
MUEVELO
1 other identifier
interventional
122
1 country
1
Brief Summary
Cycloergometer is a validated method for different care. This kind of device allow passive and active care for patient. The interest of cycloergometer for patient hospitalized in Intensive Care Unit for Sepsis has never been demonstrated. The main objective of this study is to determine the impact of early mobilization by cyclo-ergometer in association with standard physiotherapy, on the ICU length in patients with septic shock The secondary objectives of this study are to assess the impact of early mobilization by cyclo-ergometer in association with standard physiotherapy on:
- 1.the duration between hemodynamic stability\* and the removal of sedation
- 2.the duration between the removal of sedation and ICU discharge
- 3.the mechanical ventilation duration (invasive and noninvasive)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable sepsis
Started Dec 2016
Longer than P75 for not_applicable sepsis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 16, 2016
CompletedFirst Posted
Study publicly available on registry
August 19, 2016
CompletedStudy Start
First participant enrolled
December 14, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 21, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 21, 2020
CompletedMarch 29, 2022
March 1, 2022
3.4 years
August 16, 2016
March 14, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of days between hemodynamic stability and ICU discharge
Number of days between hemodynamic stability (after beginning of hospitalization for sepsis) and ICU discharge
approximately 1 month
Secondary Outcomes (2)
Number of days between hemodynamic stability and the removal of sedation
From 3 to 10 days
Number of days under mechanical ventilation (invasive and noninvasive) during hospitalization in ICU
From 3 to 10 days
Study Arms (2)
Early mobilisation with cyclo ergometer
EXPERIMENTALEarly mobilisation with cyclo ergometer in addition of Standard physiotherapy during sepsis for patient with sepsis in ICU
Standard physiotherapy
ACTIVE COMPARATORStandard physiotherapy during sepsis for patient with sepsis in ICU
Interventions
Early mobilisation with cyclo ergometer is done daily during hospitalization for sepsis in an Intensive Care Unit
Standard physiotherapy included passive and active manual mobilization, sitting on bed, sitting in chair, walking
Eligibility Criteria
You may qualify if:
- Patient hospitalized in ICU
- Patient hemodynamically stable, before the 72th hour following the diagnosis of septic shock
- Mechanical ventilation by tracheal intubation
- Patient sedated with a RASS score inferior or equal to -2
- Age ≥ 18 years
- BMI ≤ 40 kg / m²
- Informed patient having signed the consent
- Effective contraception in women of childbearing age (pregnancy test by B-HCG will be done; for menopausal women, a diagnosis of confirmation must be obtained).
You may not qualify if:
- BMI\> 40kg / m²
- Patient reduced by one or two lower limbs
- Rheumatological pathology, trauma or surgery of the lower limbs, pelvis or spine resulting of any limitations of the range of motions or strict immobilization
- Brain-injured patient and / or medulla injured
- Hemodialysis continues with a femoral catheter without possibility of changing the catheter location
- Moribund patient, Stop or Limitation of Active Therapeutics' decision
- Contraindications to standard physical therapy or the cyclo-ergometer
- Untreated orthopedics: deep vein thrombosis of the member concerned
- Dermatological: severe lesions or complex dressings in the sector concerned
- Patient with ExtraCorporeal Membrane Oxygenation (ECMO)
- Pregnant or breastfeeding women
- Patient participating in another trial with the same main objective
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rouen University Hospital
Rouen, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gaétan BEDUNEAU, MD
University Hospital, Rouen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 16, 2016
First Posted
August 19, 2016
Study Start
December 14, 2016
Primary Completion
April 21, 2020
Study Completion
April 21, 2020
Last Updated
March 29, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share